Form 8-K - Current report:
SEC Accession No. 0001104659-23-054826
Filing Date
2023-05-02
Accepted
2023-05-02 09:02:54
Documents
18
Period of Report
2023-05-01
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314233d2_8k.htm   iXBRL 8-K 37398
2 EXHIBIT 99.1 tm2314233d2_ex99-1.htm EX-99.1 2106145
6 GRAPHIC tm2314233d2_ex99-1sp3img01.jpg GRAPHIC 28454
7 GRAPHIC tm2314233d2_ex99-1sp8img001.jpg GRAPHIC 61218
8 GRAPHIC tm2314233d2_ex99-1img001.jpg GRAPHIC 216892
9 GRAPHIC tm2314233d2_ex99-1img002.jpg GRAPHIC 274172
10 GRAPHIC tm2314233d2_ex99-1img003.jpg GRAPHIC 247677
  Complete submission text file 0001104659-23-054826.txt   3868686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lci-20230501.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lci-20230501_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lci-20230501_pre.xml EX-101.PRE 22592
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2314233d2_8k_htm.xml XML 3603
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31298 | Film No.: 23876836
SIC: 2834 Pharmaceutical Preparations